Publications by authors named "S Karuna"

Claim this Profile
V
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.
Carolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, Elena E Giorgi, Craig A Magaret, Shelly Karuna

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study.
Nonhlanhla N Mkhize, Shuying Sue Li, Jiani Hu, Samuel T Robinson, Zaheer Hoosain, Shelly Karuna

PLOS Glob Public Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study.
Yunda Huang, Lily Zhang, Huub Gelderblom, Kelly E Seaton, Nicole L Yates, Shelly T Karuna

EBioMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
Carolyn Williamson, Chivonne Moodley, Craig A Magaret, Elena E Giorgi, Morgane Rolland, Shelly T Karuna

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data.
Shelly Karuna, Fatima Laher, Sufia Dadabhai, Pei-Chun Yu, Doug Grove

J Int AIDS Soc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis